Verana Health Introduces AI Agent Claire for MIPS Data Submissions
Verana Health has released Agent Claire, an artificial intelligence agent designed to assist clinicians with data reporting for the Merit-based Incentive Payment System (MIPS), announced in a press release. The tool aims to simplify the submission process, reduce compliance risks, and improve reporting efficiency.
Agent Claire is integrated into the Quality Measures Dashboard used by qualifying members of the American Academy of Ophthalmology's IRIS Registry. The system unifies clinical data to help users meet MIPS requirements and maintain accuracy while keeping pace with frequent regulatory updates.
According to Verana Health, the AI agent draws on the company’s experience in MIPS compliance support to guide medical practices in submitting accurate data and monitoring performance thresholds. The company plans to expand the agent’s capabilities across its suite of software applications for life sciences organizations.
Verana Health will host a webinar titled “From Rescue to Resilience: Boost Efficiency and Compliance in MIPS Submissions” on May 14 to provide further details about Agent Claire and its use in clinical workflows.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Kipu Health Launches AI Agent for Behavioral Health Reviews
WeInfuse and Clarion Connect AI Agents to Infusion Workflows
Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics
Verisk Adds Insurance Data to Amazon Quick, Copilot and Claude
Vera Health raises $28.5M for clinical AI search
Daily AI Brief: the AI news that matters, in your inbox.